Novo Nordisk and Orsted troubles spark fears Denmark faces its own 'Nokia moment'

Novo Nordisk and Orsted troubles spark fears Denmark faces its own 'Nokia moment'

Novo Nordisk layoffs and Orsted’s offshore wind troubles expose the risks of Denmark’s reliance on a handful of corporate giants

StockWatch: Analysts See Pain, and Necessity, in Novo Nordisk's 9,000 Layoffs

Novo Nordisk (NASDAQ Copenhagen: NOVO-B) inflicted much pain—and much-needed pain—on the company when president and CEO Maziar (Mike) Doustdar announced plans to lay off about 9,000 of its 78,400 employees, a spot check of analyst comments by StockWatch found this past week. The Danish biotech shook the biopharma industry on Wednesday when it revealed a restructuring that will not only eliminate about 11.5% of its global workforce but also slice…